1. Spellberg B, Guidos R, Gilbert D. Infectious Diseases Society of America. Antimicrobial stewardship as a medicare condition of participation. Clin Infect Dis. 2008;46:155–64.
2. Boucher T, Talbot G, Bradley J, Edwards J, Gilbert D, Rice L, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12.
3. World Health Organization. Antimicrobial resistance: global report on surveillance. 2014; Available at: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 . Accessed July 2015.
4. Infectious Diseases Society of America. Bad Bus, No Drugs. 2004; Available at: http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/Current_Topics_and_Issues/Advancing_Product_Research_and_Development/Bad_Bugs_No_Drugs/Statements/As%20Antibiotic%20Discovery%20Stagnates%20A%20Public%20Health%20Crisis%20Brews.pdf . Accessed July 2015.
5. U.S. Food and Drug Administration. New FDA task force will support innovation in antibacterial drug development. 2012; Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm320643.htm . Accessed July 22 2015.